<DOC>
	<DOC>NCT00102154</DOC>
	<brief_summary>A study to evaluate the safety and effectiveness of an investigational drug for insomnia (a sleep disorder).</brief_summary>
	<brief_title>An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>Healthy adults who are between the ages of 18 and 64 Adults who are diagnosed with insomnia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>